| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |